Regulatory Rapporteur September 2015
FOCUS: Biosimilar medicines PLUS • Toxicological approaches to impurities • Risk management for medical devices • Regulating generic veterinary medicines
Regulatory Rapporteur September 2015MEMBERS
Surveying the regulatory landscape from a toxicological perspectiveMEMBERS
Medical device risk managementMEMBERS
TOPRA/RPIF joint meeting: Key topics in education for regulatory professionalsMEMBERS
Interview: BfArM's Prof Dr med Karl BroichMEMBERS
Interview: Dr Christian Schneider, Chair of EMA's Biosimilar Medicinal Products Working PartyMEMBERS
Veterinary Medicines Q&A: The Veterinary Medicines ExchangeMEMBERS
Quality attributes in the making and breaking of biosimilarityMEMBERS
The future of biosimilars – monoclonal antibodies and beyond PUBLIC
Editorial: A new generation of biosimilars PUBLIC